Thermo Fisher ScientificvsVerrica Pharmaceuticals

TMO and VRCA stock compared: price, dividend, valuation and results, from SEC filings.

TMO

Thermo Fisher Scientific Inc

$697.22

Value $259B

-0.43%
TMO's page

VRCA

Verrica Pharmaceuticals Inc.

$3.38

Value $58M

-4.92%
VRCA's page

Thermo Fisher Scientific (TMO) has a market value of $259B and Verrica Pharmaceuticals (VRCA) $58M. Over the last year, with dividends, TMO moved +20.9% and VRCA -14.0%. Dividend yield: TMO 0.26%, VRCA none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    TMO$259B

    VRCA$58M

    TMO is 4,454 times VRCA

  • Revenue, 12 months

    TMO$47.4B

    VRCA$23M

    TMO is 2,069 times VRCA

  • Net income, 12 months

    TMO$7.1B

    VRCA-$43M

  • Operating margin

    TMO17.9%

    VRCA-184.2%

    202.1 points apart

  • ROIC

    TMO8.2%

    VRCA-93.6%

    101.8 points apart

  • P/E

    TMO36.6

    VRCA–

  • Dividend yield

    TMO0.3%

    VRCA0.0%

    0.3 points apart

  • 5-year return

    TMO+11.8%

    VRCA-97.2%

    109.0 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

TMO+11.8%

VRCA-97.2%

05010020222023202420252026
Returns by period
PeriodTMOWith dividendsVRCAWith dividends
1 year since November 14, 2025+20.9%Price +20.5%-14.0%Price -14.0%
3 years since November 16, 2023+49.0%+14.2% a yearPrice +47.6%-90.3%-54.0% a yearPrice -90.3%
5 years since November 15, 2021+11.8%+2.3% a yearPrice +10.3%-97.2%-51.1% a yearPrice -97.2%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

TMOThermo Fisher ScientificVRCAVerrica Pharmaceuticals

Valuation

TMOVRCA
Valuation
Price$697.22$3.38
Market value$259B$58M
Enterprise value (EV)$294B$57M
P/E36.6–
P/E, 5-year median32.7–
P/B4.7–
EV/EBIT34.8–
Free cash flow yield2.9%–

Results and growth

TMOVRCA
Results and growth
Revenue, 12 months$47.4B$23M
Net income, 12 months$7.1B-$43M
Free cash flow, 12 months$7.6B-$18M
Earnings per share, 12 months$18.96-$2.30
Revenue growth, year on year3.9%370.2%
Revenue growth a year, past+6.7%over 5 years+31.2%over 4 years
EPS growth a year, past+2.1%over 5 years–

Margins and returns on capital

TMOVRCA
Margins and returns on capital
Gross margin––
Operating margin17.9%-184.2%
Net margin14.9%-189.2%
ROIC8.2%-93.6%
ROE13.4%-980.4%

Balance sheet

TMOVRCA
Balance sheet
Cash$6.1B$14M
Total debt$41.4B$13M
Net debt / EBITDA3.7–
Interest cover5.5×-21.9×

Dividends and buybacks

TMOVRCA
Dividends and buybacks
Dividend yield0.3%–
Dividend per share, 12 months$1.84–
Dividend growth a year, past+14.3%over 5 years–
Buyback yield1.2%–
Shareholder yield1.4%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: TMO or VRCA

Didn't find what you were looking for?

Ask us
Which is bigger, Thermo Fisher Scientific or Verrica Pharmaceuticals?

By market value, Thermo Fisher Scientific ($259B) is about 4,454.1 times Verrica Pharmaceuticals ($58M), at today's prices.

How did TMO and VRCA stock do over the last 5 years?

Since November 15, 2021, TMO's price moved +10.3% and VRCA's -97.2%. With dividends: TMO +11.8% (+2.3% a year), VRCA -97.2% (-51.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, TMO or VRCA?

The dividend yield at today's price is 0.26% for Thermo Fisher Scientific and none for Verrica Pharmaceuticals. Over the last twelve months they paid $1.84 and – per share.

Which has the higher profit margins, Thermo Fisher Scientific or Verrica Pharmaceuticals?

Over the last twelve months, the net margin was 14.9% for Thermo Fisher Scientific and -189.2% for Verrica Pharmaceuticals, and the operating margin 17.9% and -184.2%. Revenue was $47.4B and $23M.

Which is the better investment, Thermo Fisher Scientific or Verrica Pharmaceuticals?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.